The vaccines are intended to be developed for use against Marburg virus and Sudan ebolavirus, two hemorrhagic fevers in the ...

While there are no licensed vaccines for Sudan ebolavirus, a randomized clinical trial of the recombinant vesicular stomatitis virus candidate was launched within 4 days of the outbreak’s ...

There are five subspecies of the Ebola virus: Zaire ebolavirus (EBOV), Bundibugyo ebolavirus (BDBV), Sudan ebolavirus (SUDV), Taï Forest ebolavirus (TAFV) and Reston ebolavirus (RESTV). Click ...

In next steps, as part of the Solidarity trial the WHO launched during the 2022 Sudan virus disease outbreak, Uganda will resume testing a two-antibody pan-Ebolavirus cocktail drug called MBP134 ...

Vaccine development could help lessen the burden. Most often, Ebola outbreaks have been caused by the Zaire type of the Ebola virus (Zaire ebolavirus) and the Sudan type (Sudan ebolavirus).

Vaccine development could help lessen the burden. Most often, Ebola outbreaks have been caused by the Zaire type of the Ebola virus (Zaire ebolavirus) and the Sudan type (Sudan ebolavirus).

A new study finds that the Sudan virus, a deadly Ebola relative, binds to human NPC1 receptors with nine times greater affinity than Ebola. Using cryo-electron microscopy, researchers mapped its ...

Uganda’s battle with the Sudan ebolavirus highlights the impactful work WHO does in saving lives across the region and beyond. “This outbreak showed us the importance of preparation, coordination, and ...

Laboratory at Makerere University Walter Reed Project, where Sabin’s Phase 2 Sudan ebolavirus vaccine clinical trial begins this month. WASHINGTON, July 15, 2024 (GLOBE NEWSWIRE) -- Sabin ...

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine GlobeNewswire July 15, 2024 Sudan ebolavirus is a filovirus, in the same family as Marburg virus disease and ...